Metraipolis › archive › dc_765dbb5b866e

EU HTA Regulation and Joint Clinical Assessment-Threat or Opportunity? — Europe PMC PMID:38808311

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/38808311
DOI
10.3390/jmahp12020008
License (as archived)
solo-consultazione
Archived
2026-10-08T04:15:29.189Z
SHA-256 of the archived text
77ec002e80513e9030ac4b0dce0681245a9debfe541169f918a247342504d199
Stable URL of this page
https://metraipolis.com/documento/dc_765dbb5b866e

How to cite

EU HTA Regulation and Joint Clinical Assessment-Threat or Opportunity? — Europe PMC PMID:38808311 — Europe PMC (en), https://europepmc.org/article/MED/38808311 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_765dbb5b866e (Metraipolis archive dc_765dbb5b866e, sha256 77ec002e80513e9030ac4b0dce0681245a9debfe541169f918a247342504d199)
BibTeX
@misc{dc765dbb5b866e,
  title = {EU HTA Regulation and Joint Clinical Assessment-Threat or Opportunity? — Europe PMC PMID:38808311},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/38808311},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_765dbb5b866e; sha256 77ec002e80513e9030ac4b0dce0681245a9debfe541169f918a247342504d199},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/38808311. Agents can read the archived copy with the MCP tool read_document.